For everyone · 17 min · Worth watching
The 60 Minutes peptide warning, published by a peptide supplier
60 Minutes Australia — Investigative current-affairs programme, Nine Network
This is a national broadcaster warning people about the business we are in. We are putting it on our own website, near the top, because a supplier who only shows you the flattering coverage has told you something about themselves that no amount of certification can offset.
What it gets right, from where we sit
The concerns in the segment are the correct concerns. Material of uncertain origin. Claims that outrun the evidence. Compounds sold as research use only and used in people anyway. Doses arrived at by consensus on a forum rather than by trial. Every one of those is real, all of them are common, and none of them is a media exaggeration.
It is also the reason this business is organised the way it is: we supply licensed clinical operators, not individuals, and what we can put in a buyer's hands is documentation — what the material is, where it was made, what testing the specific lot passed. That is a narrower offer than the trade generally makes. This segment is a good illustration of why the narrower offer is the defensible one.
What we are not going to do
Rebut it point by point. A supplier arguing with a journalist about whether the concerns are overstated is not a good look and would not be honest — the concerns are not overstated. Watch it, take the questions it raises, and put them to whoever is proposing to sell you something. Including us.
What to watch for
- The distinction between a compound with human trial data and one with none. It carries most of the weight in the whole segment.
- What is said about research use only labelling. If a supplier uses that phrase and also implies human use, those two things cannot both be operative.
- Every question the reporters put to sellers. Those are your questions, and you are entitled to answers that are documented rather than reassuring.
